Cefpodoxime Proxetil CAS:87239-81-4
Cefpodoxime proxetil is prescribed by healthcare providers for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, and pharyngitis caused by susceptible bacteria. Patients should consult with a healthcare professional before using cefpodoxime proxetil to determine the appropriate dosage and duration of treatment based on the specific type and severity of the infection. Patients typically take cefpodoxime proxetil orally as directed by their healthcare provider. It is important to complete the full course of treatment even if symptoms improve before completion to ensure the eradication of the bacterial infection and prevent recurrence. While cefpodoxime proxetil is generally well-tolerated, common side effects may include gastrointestinal disturbances, headache, or allergic reactions. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be reported to a healthcare provider promptly for evaluation and management. Overall, cefpodoxime proxetil is an effective oral antibiotic used to combat bacterial infections when administered correctly under medical guidance.
Composition | C21H27N5O9S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 87239-81-4 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |